CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

1,017

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

February 15, 2027

Study Completion Date

February 15, 2027

Conditions
Colorectal Cancer
Interventions
DEVICE

MRD

ctDNA MRD test

Trial Locations (32)

15232

UPMC Hillman Cancer Center, Pittsburgh

17403

WellSpan York Cancer Center, York

19096

Lankenau Medical Center, Wynnewood

19611

Reading Hospital Hematology Oncology, West Reading

21093

University of Maryland St. Joseph Medical Center, Towson

21237

MedStar Georgetown Cancer Institute at MedStar Georgetown University Hospital, Baltimore

21742

Meritus Center for Clinical Research, Hagerstown

27157

Atrium Health Wake Forest Baptist Medical Center, Winston-Salem

28204

Atrium Health Levine Cancer Institute, Charlotte

28374

FirstHealth Outpatient Cancer Center, Pinehurst

29605

Primsa Health Cancer Institute, Greenville

32610

University of Florida Division of Hematology & Oncology, Gainesville

32763

Mid Florida Cancer Centers, Orange City

33140

Mount Sinai Medical - Comprehensive Cancer Center, Miami Beach

37660

Ballad Health Cancer Center, Kingsport

43215

Columbus NCORP, Columbus

52403

Mercy Medical Center, Cedar Rapids

54476

Marshfield Medical Center Weston, Weston

55426

Metro Minnesota Community Oncology Consortium (MMCORC), Saint Louis Park

57104

Sanford Cancer Center, Sioux Falls

58104

Sanford Roger Maris Cancer Center, Fargo

60126

Edward Cancer Center, Elmhurst

61615

Illinois Cancer Care, Peoria

63131

Missouri Baptist Medical Center, St Louis

66205

University of Kansas Cancer Center, Westwood

90505

Torrance Memorial Hunt Cancer Institute, Torrance

91345

Facey Medical Group - Mission Hills - Endoscopy Center & Gastroenterology, Mission Hills

97227

Interstate Medical Office Central, Portland

T6G1Z2

Cross Cancer Institute, Edmonton

M5G2C1

Princess Margaret Cancer Center, Toronto

H3T1E2

Jewish General Hospital, Montreal

H4A3J1

McGill University Health - Glen Site, Montreal

Sponsors
All Listed Sponsors
collaborator

NSABP Foundation Inc

NETWORK

lead

Exact Sciences Corporation

INDUSTRY

NCT05210283 - CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer | Biotech Hunter | Biotech Hunter